Navigation Links
Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors
Date:5/11/2009

On May 12, Physicians for Human Rights and a coalition of organizations from more than 16 countries will hold a Global Day of Action calling on the Iranian government to drop the charges and immediately release Kamiar and Arash Alaei.

(Vocus) May 11, 2009 -- While the international community celebrates the release of detained US journalist Roxana Saberi, there is still continuing vigilance over the unjust imprisonments of Drs. Kamiar and Arash Alaei. These Iranian brothers are world-renowned HIV/AIDS physicians who were imprisoned since June by the Iranian government on unsubstantiated charges of communicating with an "enemy government."

On May 12, Physicians for Human Rights and a coalition of organizations from more than 16 countries will hold a Global Day of Action calling on the Iranian government to drop the charges and immediately release Kamiar and Arash Alaei. Participants from around the world will make statements to Iranian authorities and join a live webcast of vigils and events on an interactive website, IranFreetheDocs.org.

"Physicians for Human Rights believes that treating AIDS is not a crime--it's good medicine", said Sarah Kalloch, Director of Outreach for Physicians for Human Rights.

The Alaei brothers traveled the world to share Iran's model of HIV prevention and treatment, not to recruit people to foment a "velvet revolution," as alleged by the Iranian government. Such allegations hurt the future of public health and indicate a dangerous trend toward punishing health professionals for working in the US.

"Just as Iran conflated freedom of the press with espionage in the trial of Saberi, Iran has equated public health diplomacy with treason in the case of the Alaeis. This is a terribly dangerous stance in an era of global pandemics which require open medical collaboration to save lives," said Kalloch.

"The Alaeis are on their final appeal. Health workers and human rights advocates from 129 countries have signed a petition calling for their release. It's time for Iran to stand up and protect freedom of science--and the lives of Iranians--by releasing the Alaeis," said Jonathan Hutson, Chief Communications Officer at Physicians for Human Rights.

In January, Dr. Kamiar Alaei and his brother Dr. Arash Alaei were sentenced to prison terms of three and six years, respectively, in Tehran's notorious Evin Prison. At no point has the Iranian prosecutor made public any shred of evidence to support his contention that the brothers were involved in any international activity other than the fight against global AIDS.

According to sources close to the Alaei brothers' case, the appellate court received their appeals on March 17 and the following day - without a hearing - summarily rejected their appeals and upheld their sentences.

Their attorney, Massoud Shaffiie filed a final appeal on May 7 to Iran's judiciary chief Ayatollah Mahmoud Hashemi Shahrudi under Article 118 of the Iranian Constitution.

"The case of these world-renowned HIV/AIDS physicians is part of a crackdown on international scientific and academic exchange which undermines efforts of all who seek to treat global AIDS and protect the health of the Iranian people. Their imprisonment robs the world of two talented physicians and has a chilling effect on public health dialogue and diplomacy worldwide," Hutson said. "It appears that the jailing of people on trumped-up charges has more to do with appeasing the conservatives in advance of Iran's national elections in June."

Dr. Kamiar Alaei is a doctoral candidate at the SUNY Albany School of Public Health in Albany, New York and was expected to resume his studies there in the fall of 2008. In 2007, he received a Master of Science degree in Population and International Health from the Harvard School of Public Health.

Dr. Arash Alaei is the former director of the International Education and Research Cooperation of the Iranian National Research Institute of Tuberculosis and Lung Disease. Since 1998, the Drs. Alaei have been carrying out HIV/AIDS treatment and prevention programs, particularly focused on harm reduction for injecting drug users.

In addition to their work in Iran, the Alaei brothers have held training courses for Afghan and Tajik medical workers and have worked to encourage regional cooperation among 12 Middle Eastern and Central Asian countries. Their efforts expanded the expertise of doctors in the region, advanced the progress of medical science, and helped earn Iran recognition as a model of best practice by the World Health Organization.

Media Contact:
Jonathan Hutson
jhutson (at) phrusa (dot) org
Cell: (857) 919-5130

# # #

Read the full story at http://www.prweb.com/releases/HIV-AIDS/Kamiar-Arash-Alaei/prweb2409054.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
2. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
3. First New York/New Jersey Health Care Report Card Released
4. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
5. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
6. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
7. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
8. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
9. Verdict One Releases Directory of Board Certified Attorneys for Consumers
10. Academy releases emergency preparedness tools to enable millions more people to shelter in place
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors
(Date:2/10/2016)... ... February 10, 2016 , ... ... as the World Molecular Imaging Congress (WMIC), will be held in New York ... meeting is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging ...
(Date:2/10/2016)... Rancho Mirage, California (PRWEB) , ... February 10, ... ... Care Dental are working together to expand dental health services to the developmentally ... have moved We Care Dental’s operations to a new facility at 71-949 Highway ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy ... to associations of medical professionals throughout the country. The Guard was specifically designed ... policies and procedures, employee training, regulatory updates, and compliance coaching. , In addition ...
(Date:2/10/2016)... Thornton, CO (PRWEB) , ... February 10, 2016 , ... ... to announce the practice is now accepting new dental patients and families in the ... expect exceptional dental care services from cleanings to cosmetic dentistry, and all in the ...
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral ... December 31, 2015 on Monday, February 29, 2016 after the market closes. , The ... release at 4:30 PM ET. Investors interested in participating by phone are invited to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016  The ALS Association, in partnership with ALS Finding ... generate a biomarker to track TDP43 aggregation. The successful team(s) ... $1 million investment. --> ... nerve cells in the brain and the spinal cord. Eventually, ... muscle movement, which often leads to total paralysis and death ...
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... CORAL SPRINGS, Florida , February 10, 2016 ... Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, ... Medivation, Inc. (NASDAQ: MDVN ), Adamas Pharmaceuticals, Inc. (NASDAQ: ... ). --> Today,s latest Orphan Drug Designations become ... granted by the FDA to novel drugs and biologics which ...
Breaking Medicine Technology: